Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Wiley 2021

Ижил төстэй зүйлс

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
-н: Xu, S, зэрэг
Хэвлэсэн: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
-н: Wamil, M, зэрэг
Хэвлэсэн: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
-н: Leal, J, зэрэг
Хэвлэсэн: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
-н: Califf, R, зэрэг
Хэвлэсэн: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
-н: Currie, G, зэрэг
Хэвлэсэн: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
-н: Liam Mc Morrow, зэрэг
Хэвлэсэн: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
-н: M. N. Mamedov
Хэвлэсэн: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
-н: Holman, R, зэрэг
Хэвлэсэн: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
-н: Yates, T, зэрэг
Хэвлэсэн: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
-н: Yates, T, зэрэг
Хэвлэсэн: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
-н: Wamil, M, зэрэг
Хэвлэсэн: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
-н: Susanne Andersson, зэрэг
Хэвлэсэн: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
-н: Nihar Ranjan Mohanty, зэрэг
Хэвлэсэн: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
-н: Wamil, M, зэрэг
Хэвлэсэн: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
-н: Farrer, M, зэрэг
Хэвлэсэн: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
-н: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Хэвлэсэн: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
-н: Preiss, D, зэрэг
Хэвлэсэн: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
-н: Califf, R, зэрэг
Хэвлэсэн: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
-н: Holman, R
Хэвлэсэн: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
-н: Yutaka Inoue, зэрэг
Хэвлэсэн: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
-н: Page, R, зэрэг
Хэвлэсэн: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
-н: Ursula Mager, зэрэг
Хэвлэсэн: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
-н: Xin Zhang, зэрэг
Хэвлэсэн: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
-н: Anke Tönjes, зэрэг
Хэвлэсэн: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
-н: Huibin Huang, зэрэг
Хэвлэсэн: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
-н: Gerstein, H, зэрэг
Хэвлэсэн: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
-н: Preiss, D, зэрэг
Хэвлэсэн: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
-н: Zhen Yang, зэрэг
Хэвлэсэн: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
-н: Dos Santos, M, зэрэг
Хэвлэсэн: (2017)

Impaired glucose tolerance in sleep disorders.
-н: Marietta Keckeis, зэрэг
Хэвлэсэн: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
-н: Stevens, R, зэрэг
Хэвлэсэн: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
-н: Brkić Milena, зэрэг
Хэвлэсэн: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
-н: Yupu Liu, зэрэг
Хэвлэсэн: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
-н: Mostafa, SA, зэрэг
Хэвлэсэн: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
-н: Mc Morrow, L, зэрэг
Хэвлэсэн: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
-н: Lu Yu, зэрэг
Хэвлэсэн: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
-н: Marilia Harumi Higuchi dos Santos, зэрэг
Хэвлэсэн: (2017-01-01)

List of people who have paid
-н: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
-н: Latini, R, зэрэг
Хэвлэсэн: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
-н: Sharma, A, зэрэг
Хэвлэсэн: (2016)